Human CTLA-8 / IL-17a Antibody (Netakimab, Research Use)

产品名称	Human CTLA-8 / IL-17a Antibody (Netakimab, Research Use)
目录号	NBR-0628
别名	IL-17A; IL-17; CTLA8
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0628-100UG	100ug	￥550	请咨询
NBR-0628-1MG	1mg	￥3500	请咨询
NBR-0628-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human CTLA-8 / IL-17a Antibody (Netakimab, Research Use)
产品编号：NBR-0628
针对靶点：CTLA-8 / IL-17a
抗体药商品名：Netakimab
抗体药描述：Netakimab (NTK) is a humanized anti-IL-17A antibody approved for the treatment of AS, psoriatic arthritis, moderate-to-severe plaque psoriasis in Russia and Belarus.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: CTLA-8
Synonyms: IL-17A; IL-17; CTLA8
Target Description: IL17A (Interleukin 17A) is a Protein Coding gene. Diseases associated with IL17A include Allergic Contact Dermatitis and Bronchiolitis Obliterans. Among its related pathways are MIF Mediated Glucocorticoid Regulation and TGF-Beta Pathway. Gene Ontology (GO) annotations related to this gene include cytokine activity. An important paralog of this gene is IL17F.
Ensembl: ENSG00000112115
Uniprot: Q16552